While adaptor-only and SNAP-CAR T cell only controls showed rapid tumor growth, both SNAP-CAR T cells with adaptor and anti-HER2 traditional CAR T cell treatment groups showed significant inhibition of tumor growth in all mice and had 4/5 mice showing no signs of tumor growth at day 60. This evidence concerns the gene ERBB2 and neoplasm.